Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gorlin Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00025012
What this trial is testing

Isotretinoin in Preventing Skin Cancer

Who this might be right for
Melanoma (Skin)Non-melanomatous Skin Cancer
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Testing effectiveness (Phase 2)Study completedNCT00489086
What this trial is testing

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

Who this might be right for
Neoplastic Syndrome
UCSF Benioff Children's Hospital Oakland 36
Not applicableEnrolling By InvitationNCT06330324
What this trial is testing

Reproductive Options in Inherited Skin Diseases

Who this might be right for
IchthyosisPalmoplantar KeratosesEpidermolysis Bullosa+7 more
Maastricht University Medical Center 650
Testing effectiveness (Phase 2)Study completedNCT02762084
What this trial is testing

Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients

Who this might be right for
Basal Cell Nevus Syndrome
PellePharm, Inc. 17
Not applicableLooking for participantsNCT03050268
What this trial is testing

Familial Investigations of Childhood Cancer Predisposition

Who this might be right for
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
St. Jude Children's Research Hospital 1,500
Testing effectiveness (Phase 2)Study completedNCT01556009
What this trial is testing

Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas

Who this might be right for
Basal Cell Nevus SyndromeGorlin's Syndrome
UCSF Benioff Children's Hospital Oakland 24
Early research (Phase 1)Study completedNCT02639117
What this trial is testing

Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinoma
University of Arizona 4
Testing effectiveness (Phase 2)Ended earlyNCT04155190
What this trial is testing

Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Who this might be right for
Recurrent Basal Cell Carcinoma
Sol-Gel Technologies, Ltd. 50
Testing effectiveness (Phase 2)Ended earlyNCT02303041
What this trial is testing

Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Carcinoma, Basal CellRecurrent Skin CancerSkin Neoplasms+1 more
Anne Chang 10
Not applicableStudy completedNCT00555633
What this trial is testing

Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients

Who this might be right for
Skin CancerXeroderma PigmentosumBasal Cell Nevus Syndrome
Medical University of Graz 13
Testing effectiveness (Phase 2)Ended earlyNCT02002689
What this trial is testing

LDE225 for Patients With PTCH1 or SMO Mutated Tumors

Who this might be right for
PTCH1 or SMO Activated Solid and Hematologic Tumors
Novartis Pharmaceuticals 10
Early research (Phase 1)Study completedNCT01463709
What this trial is testing

Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer

Who this might be right for
Basal Cell Carcinomas
UCSF Benioff Children's Hospital Oakland 4
Testing effectiveness (Phase 2)Temporarily pausedNCT03208296
What this trial is testing

Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)

Who this might be right for
Basal Cell Carcinoma in Basal Cell Nevus Syndrome
Ascend Biopharmaceuticals Ltd 24
Early research (Phase 1)Study completedNCT03467789
What this trial is testing

Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma

Who this might be right for
Basal Cell CarcinomaBasal Cell Nevus Syndrome
Case Comprehensive Cancer Center 37
Not applicableStudy completedNCT00005660
What this trial is testing

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

Who this might be right for
Basal Cell CarcinomaKeratosis Palmaris et PlantarisPsoriasis
National Cancer Institute (NCI) 130
Early research (Phase 1)Study completedNCT00433485
What this trial is testing

Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants

Who this might be right for
Neoplastic SyndromeNon-melanomatous Skin Cancer
Yale University 16
Not applicableStudy completedNCT01014819
What this trial is testing

A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions

Who this might be right for
Basal Cell Carcinoma
UCSF Benioff Children's Hospital Oakland 30
Not applicableStudy completedNCT01893892
What this trial is testing

Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

Who this might be right for
Musculoskeletal Complications
Stanford University 12
Testing effectiveness (Phase 2)Study completedNCT01815840
What this trial is testing

Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinoma
Hoffmann-La Roche 229
Testing effectiveness (Phase 2)Study completedNCT02828111
What this trial is testing

Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinomas
PellePharm, Inc. 36
Next Page